Determinants of HIV serostatus disclosure and assessment of the competence of health care personnel in HIV serostatus disclosure

  • MO Adekunle
  • OA Olutekunbi
  • BA Animasahun
  • MA Afadapa
  • P Ubuane
Keywords: Healthcare Personnel, Human Immunodefieicny Virus, Lagos, Childhood, Disclosure


Background: Disclosure of HIV serostatus is essential for the care and eradication of HIV infection. The World Health Organization recommends disclosure to school-age children and younger children but this practice is commonly hindered by stigmatization and other presumed psychosocial effects of the disease.
Objective: To identify limitations to the disclosure of serostatus in HIV-infected children, outcomes of disclosure as well as compare the outcomes of disclosure by either parents/caregiver only with the involvement of health care personnel.
Methods: A questionnaire-based study of primary caregivers of children aged 6 years to 18 years with HIV infection who were enrolled at two government-owned tertiary institutions in Lagos State, Nigeria. The healthcare personnel directly involved in the care of these children also participated in the study.
Results: A total of 190 primary caregivers participated in the study. In all, 29 health care personnel completely filled the questionnaires. Disclosure (partial and full) was recorded among 31.0%. Older children and children with single parents were more likely to know their HIV status. Similar positive and negative impacts of disclosure were observed irrespective of the individuals involved in the processes. In all, 62.1% of healthcare personnel have had training on disclosure.
Conclusion: Disclosure rate in HIV-infected children was low. There is a need for more training of health personnel and education of caregivers on the benefits of disclosure as well as the introduction of effective measures to tackle the barriers to disclosure.


Deeks SG, Lewis SR, Havlir DV. The end to AIDS: HIV infection as a chronic disease. Lancet 2013; 382(9903): 1525-1533.

Atuyambe LM, Ssegujja E, Ssali S, Tumwine C, Nekesa N, Nannungi A, et al. HIV/AIDS disclosure increases support, behavioural change and, HIV prevention in the long term: a case for an urban clinic, Kampala, Uganda. BMC Health Services Res 2014; 14: 276.

World Health Organization. WHO guidelines on HIV disclosure counselling for children up to 12 years of age. 2011.

GBD 2013 Mortality and Causes of Death Collaborators 2015. Global, regional and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet 2015; 385: 117-171.

UNICEF Annual Results 2014. HIV and AIDS.

WHO. Guideline on HIV disclosure counselling for children. 2011. Accessed 5th December 2018

Ogunlesi TA, Dedeke IOF, Kuponiyi OT. Socioeconomic classification of children attending Specialist Paediatric Centres in Ogun State, Nigeria. Niger Med Pract 2008; 54(1): 21-25.

Obiagwu PN, Hassan-Hanga F, Ibrahim. Paediatric HIV in Kano, Nigeria. Niger J Clin Pract.2013; 16: 521-525.

Taha TE, Nour S, Kumwenda NI, Broadhead RL, Fiscus SA, Kafulafula G, et al. Gender differences in perinatal HIV acquisition among African infants. Paediatrics 2005; 115(2): e167-e172.

Hayfron-Benjamin A, Obiri-Yeboah D, Ayisi-Addo S, Siakwa PM, Mupepi S. HIV diagnosis disclosure to infected children and adolescents; challenges of family caregivers in the Central region of Ghana. BMC Paediatr 2018; 18: 365.

Brown BJ, Oladokun RE, Osinusi K, Ochigbo S, Adewole IF, Kanki P. Disclosure of HIV status to infected children in a Nigerian HIV care programme. AIDS Care 2011; 23(9): 1053-1058.

Ubesie AC, Iloh KK, Emodi IJ, Ibeziako NS, Obumneme-Anyim IN, Iloh UN, et al. HIV status disclosure rate and reasons for non-disclosure among infected children and adolescents in Enugu, Southeast, Nigeria. SAHARA-J 2016; 13(1): 136-141.

Ikpeme EE, Dixon Umo DT. Disclosure of HIV diagnosis to infected children receiving care in University of Uyo Teaching Hospital, Uyo, Nigeria. J AIDS HIV Res 2016; 8(7): 93-99.

Orji ML, Onyira NB, Onwe OE. Status disclosure in HIV infected children in Abakaliki, Ebonyi State, Southeast, Nigeria. J Nepal Paediatr Soc 2017; 37(3): 244-248.

Mumburi LP, Hamel BC, Philemon RN, Kapanda GN, Msuya LJ. Factors associated with HIV-status disclosure to HIV-infected children receiving care at Kilimanjaro Christian Medical Centre in Moshi, Tanzania. Pan Afr Med J 2014; 18: 50. doi:10. 11604/pamj. 2014.18.50.2307.

Negese D, Addis K, Awoke A, Birhanu Z, Muluye D, Yifru S, et al. HIV-positive status disclosure and associated factors among children in North Gundar, Northwest Ethiopia. ISRN AIDS 2012; Article ID 485720.

Naidoo GD, McKerrow NH. Current practices around HIV disclosure to children on highly active antiretroviral therapy. South Afr J Child Health 2015; 9(3): 85-88.

Mandalazi P, Bandawe C, Umar E. HIV disclosure: a parental dilemma in informing HIV infected children about their HIV status in Malawi. Malawi Med J 2014; 26(4): 101-104.

Kalembo FW, Kendall GE, Ali M, Chimwaza AF. Healthcare workers’ perspectives and practices regarding the disclosure of HIV status to children in Malawi: a cross-sectional study. BMC Health Serv Res 2018; 18(540): 1-10.

Bulali RE, Kibusi SM, Mpondo BCT. Factors associated with HIV status disclosure and its effect on treatment adherence and quality of life among children 6-17 years on antiretroviral therapy in Southern Highlands zone, Tanzania: unmatched case-control study. Int J Paediatr .2018; Article ID 8058291.

Nichols JS, Kyriakides TC, Sampson A, Renner L, Lartey M, Seaneke OA, et al. High prevalence of non-adherence to antiretroviral therapy among undisclosed HIV-infected children in Ghana. AIDS Care 2018; 31(2): 1-10.

Oberdorfer P, Puthanakit T, Louthrenoo O, Charnsil C, Sirisanthana V, Sirisanthana T. Disclosure of HIV/AIDS diagnosis to HIV-infected children in Thailand. J Paediatr Child Health 2006; 42(5): 283-288.

Bikaako-Kajura W, Luyirika E, Purcell DW, Downing J, Kaharuza F, Mermin J, et al. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav 2006; 10 (Supl4): S85-S93.

Vreeman RC, Scanlon ML, Mirangi A, Turissini M, Ayaya SO, Tenge C, et al. A cross-sectional study of disclosure of HIV status to children and adolescents in Western Kenya. PLoS ONE 9(1): e86616.doi10.1371/journal.pone.0086616.

Binagwaho A, Murekatete I, Rukundo A, Mugwaneza P, Hinda R, Lyambabaje A, et al. Factors associated with disclosure of HIV positive children in Rwanda. RMJ 2012; 69(3): 9.

Krauss BJ, Letteney S, De Baets A, Baggaley R, Okero FA. Disclosure of HIV status to HIV-positive children 12 and under: A systematic cross-national review for health and well-being. Vuln Child Youth Stud 2013; 8(2): 99-119.

Kodyalamoole NK, Badiger S, Kiran NU, Dodderi SK, Rewari BB. Pattern of paediatric HIV status disclosure in coastal Karnataka. Indian J Med Res 2018; 147(5): 501-506.

WHO. Training. Accessed 10th February 2019.

Nzota MS, Matovu JKB, Draper HR, Kisa R, Kiwanuka SN. Determinants and processes of HIV status disclosure to HIV-infected children aged 4 to 17 years receiving HIV care services at Baylor College of Medicine Children's Foundation, Tanzania, Centre of Excellence (COE) in Mbeya: a cross-sectional study. BMC Paediatr 2015; 15: 81.

Ebuenyi ID, Ogoina D, Ikuabe PO, Harry TC, Inatimi O, Chuhwueke OU. Prevalence pattern and determinants of disclosure of HIV status in an antiretroviral therapy clinic in the Niger Delta region of Nigeria. Afr J Infect Dis 2014; 8(2): 27-30

Tsuzuki S, Ishikawa N, Miyamoto H, Dube C, Kayama N, Watala J, et al. Disclosure to HIV-seropositive children in rural Zambia. BMC Paediatr 2018; 18: 272.

Original Research